Get news updates from AACRMeetingNews.org
Subscribe below to get email updates from AACRMeetingNews.org
-
Schedule highlights from the Program Chair: Saturday, April 9
Annual Meeting Program Committee Chair Marcia R. Cruz-Correa, MD, PhD, shares a few highlights from Saturday’s schedule to help plan your day.
-
Clinical Trials Plenary Sessions will showcase clinical applications of novel therapies
Julie R. Brahmer, MD, MSc, and Timothy A. Yap, MD, PhD, preview the Annual Meeting’s four Clinical Trials Plenary Sessions, which will include important studies looking at cellular therapies, novel immunotherapeutics, and molecularly targeted therapeutics.
-
Pezcoller Award lecturer will recount decades of milestones in the development of immunotherapy
Steven A. Rosenberg, MD, PhD, FAACR, is being recognized for pioneering the development of effective immunotherapies and gene therapies for patients with advanced cancers, among other significant research contributions.
-
AACR honors elite group with scientific achievement awards and lectureships
The AACR honored dozens of cancer researchers, physician-scientists, advocates, and policymakers for their achievements during the Annual Meeting.
-
AACR CEO Margaret Foti, PhD, MD (hc): Welcome to New Orleans and the AACR Annual Meeting 2022
This year’s multidisciplinary program reflects the AACR’s focus on the various facets of cancer etiology, progression, and treatment and the factors that influence each individual patient’s experience, including genetics, environment, and lifestyle factors.
-
Annual Meeting program kicks off with dozens of Educational Sessions and Methods Workshops
The Annual Meeting program officially launches today and features 50 Educational Sessions and 13 Methods Workshops covering the hottest cancer research topics, according to Lillian L. Siu, MD, Chair of the Annual Meeting Education Committee.
-
2022 Fellows of the AACR Academy will be honored during Sunday’s Opening Session
This year’s class of 33 new Fellows joins the 256 distinguished scientists, clinicians, and physician-scientists previously honored with the AACR’s highest level of recognition.
-
Tony Hunter, PhD, FAACR, to receive AACR Award for Lifetime Achievement in Cancer Research
Hunter is being honored for the discovery of protein tyrosine phosphorylation as a common cellular mechanism capable of contributing to cellular growth and proliferation and, in some cases, the development of cancer.
-
AACR to honor Raymond N. DuBois, MD, PhD, FAACR, with Distinguished Service Award
DuBois is being honored for elucidating the role of cyclooxygenase 2 in colon cancer and the contributions of the lipid metabolite prostaglandin E2 to tissue inflammation in the etiology of colon cancer.
-
Weekend plenary sessions illustrate the diversity and depth of this year’s scientific program
Catriona H. M. Jamieson, MD, PhD (left), and Marcia R. Cruz-Correa, MD, PhD (right), preview the Precancer Discovery Science Plenary Session on Saturday, April 9, and the Opening Plenary Session on Sunday, April 10.